Winston & Strawn represented Arbor Investments and its portfolio company Crown Bakeries in the transaction. Arbor Investments and its portfolio company Crown Bakeries announced the acquisition of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Aligos Therapeutics, while Davis Polk advised the representatives of the several underwriters in the offering. Aligos Therapeutics, Inc. (Nasdaq: ALGS) announced...
You must be a Standard 1 Year member to access this content.
Davis Polk, working alongside Matheson, advised Novo Nordisk on the deal. Novo Nordisk A/S completed its acquisition of Neotope Neuroscience Limited from Prothena Biosciences Limited for...
You must be a Standard 1 Year member to access this content.
Dentons and Davis Polk advised GH Research PLC on the IPO. GH Research PLC executed its SEC-registered initial public offering of 11,499,999 ordinary shares for total...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriters in the offering. Theravance Biopharma, Inc. executed its $100.5 million public offering of ordinary shares. Theravance Biopharma’s ordinary shares are listed on the Nasdaq...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the offering. Century Therapeutics, Inc. executed the $242.7 million initial public offering of 12,132,500 shares of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the several underwriters in the IPO. Cyteir Therapeutics, Inc. executed the $133.2 million initial public offering of 7,400,000 shares of common...
You must be a Standard 1 Year member to access this content.
Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering. with a $143.7 million SEC-registered follow-on offering of 4,356,060 shares of...
You must be a Standard 1 Year member to access this content.
Homburger advised Molecular Partners AG in the transaction, while Davis Polk and Advestra advised the joint book-running managers and representatives of the underwriters. Molecular Partners AG,...
You must be a Standard 1 Year member to access this content.
Winston & Strawn represented TreeHouse Foods in the transaction. TreeHouse Foods (NYSE: THS) closed its definitive agreement and completed sale of its ready-to-eat (RTE) cereal business to...
You must be a Standard 1 Year member to access this content.
Davis Polk advised LIV Capital Acquisition Corp. on the deal. LIV Capital Acquisition Corp. (“LIVK”), a special purpose acquisition company, executed its approximately $482 million business...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agent on the offering. ImmunityBio, Inc. executed an at-the-market offering of its common stock for up to an aggregate amount of $500 million....
You must be a Standard 1 Year member to access this content.
